Catheter Ablation vs. Anti-Arrhythmic Drugs as First-Line Treatment in Symptomatic Paroxysmal Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

Catheter Ablation vs. Anti-Arrhythmic Drugs as First-Line Treatment in Symptomatic Paroxysmal Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

Background: Catheter ablation has become a well-established indication for long-term rhythm control in atrial fibrillation (AF) patients refractory to anti-arrhythmic drugs (AADs). Efficacy and safety of AF catheter ablation (AFCA) before AADs failure are, instead, questioned.Objective: The aim of t...

Full description

Bibliographic Details
Main Authors:	Andrea Saglietto, Fiorenzo Gaita, Roberto De Ponti, Gaetano Maria De Ferrari, Matteo Anselmino
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-05-01
Series:	Frontiers in Cardiovascular Medicine
Subjects:	atrial fibrillation catheter ablation rhythm control anti-arrhythmic drugs side effects
Online Access:	https://www.frontiersin.org/articles/10.3389/fcvm.2021.664647/full

Similar Items

Resource use and clinical outcomes in patients with atrial fibrillation with ablation versus antiarrhythmic drug treatment
by: Julian W. E. Jarman, et al.
Published: (2018-11-01)

A comparison of the real world effectiveness of catheter ablation and drug therapy in atrial fibrillation patients in a Chinese setting
by: Xin Du, et al.
Published: (2017-07-01)

Catheter ablation for non-paroxysmal atrial fibrillation. A review
by: Sabri Hassouna, et al.
Published: (2024-03-01)

Association of Catheter Ablation and Reduced Incidence of Dementia among Patients with Atrial Fibrillation during Long-Term Follow-Up: A Systematic Review and Meta-Analysis of Observational Studies
by: Andrea Saglietto, et al.
Published: (2022-04-01)

Long-Term Follow-Up of Catheter Ablation for Premature Ventricular Complexes in the Modern Era: The Importance of Localization and Substrate
by: Simone Gulletta, et al.
Published: (2022-11-01)

Atrial fibrillation and heart failure: A contemporary review of current management approaches
by: Justin Z. Lee, MD, et al.
Published: (2021-12-01)

Malnutrition and Risk of Procedural Complications in Patients With Atrial Fibrillation Undergoing Catheter Ablation
by: Daehoon Kim, et al.
Published: (2021-10-01)

Review of the 2020 ESC Guidelines for the Diagnosis and Management of Atrial Fibrillation—What Has Changed and How Does This Affect Daily Practice
by: Johanna B. Tonko, et al.
Published: (2021-08-01)

Catheter Ablation for Atrial Fibrillation
by: Andre J. Gauri, et al.
Published: (2003-10-01)

Cryoballoon catheter ablation or drug therapy to delay progression of atrial fibrillation: A single-center randomized trial
by: Jun Ding, et al.
Published: (2022-10-01)

The Era of Rhythm Control: A Review of the Epidemiology and Clinical Impact of Anti-Arrhythmic Medications in Atrial Fibrillation
by: Cicely Anne Dye, et al.
Published: (2023-03-01)

Efficacy and Safety of Catheter Ablation vs Antiarrhythmic Drugs as Initial Therapy for Management of Symptomatic Paroxysmal Atrial Fibrillation: A Meta-Analysis
by: Aminah Abdul Razzack, et al.
Published: (2022-03-01)

Concentrated pineapple juice for visualisation of the oesophagus during magnetic resonance angiography before atrial fibrillation radiofrequency catheter ablation
by: Riccardo Faletti, et al.
Published: (2018-11-01)

A novel individualized strategy for cryoballoon catheter ablation in patients with paroxysmal atrial fibrillation
by: Jun Ding, et al.
Published: (2019-12-01)

Long-term outcomes after radiofrequency catheter ablation of paroxysmal and persistent atrial fibrillation
by: Matjaž Šinkovec, et al.
Published: (2013-11-01)

DETECTING AND MONITORING ARRHYTHMIA RECURRENCE FOLLOWING CATHETER ABLATION OF ATRIAL FIBRILLATION.
by: Olujimi A Ajijola, et al.
Published: (2015-03-01)

Subclinical and Asymptomatic Atrial Fibrillation: Current Evidence and Unsolved Questions in Clinical Practice
by: Andrea Ballatore, et al.
Published: (2019-08-01)

Risk Factors for Stiff Left Atrial Physiology 1 Year After Catheter Ablation of Atrial Fibrillation
by: Jae-Hyuk Lee, et al.
Published: (2021-09-01)

Impact of the COVID-19 Pandemic and Public Restrictions on Outcomes After Catheter Ablation of Atrial Fibrillation
by: Daehoon Kim, et al.
Published: (2022-03-01)

Early experiences with three types of balloon-based ablation catheters in patients with paroxysmal atrial fibrillation
by: Atsushi Kobori, MD, PhD, et al.
Published: (2021-06-01)

Paroxysmal Atrial Fibrillation Catheter Ablation of Pulmonary Veins: does Anatomy Influence the Outcome?
by: Álvaro Valentim Lima Sarabanda

The occurrence of new arrhythmias after catheter-ablation of accessory pathway: Delayed arrhythmic side-effect of curative radiofrequency lesion?
by: Mujović Nebojša, et al.
Published: (2011-01-01)

Is There an Association between Epicardial Adipose Tissue and Outcomes after Paroxysmal Atrial Fibrillation Catheter Ablation?
by: Néfissa Hammache, et al.
Published: (2021-07-01)

Predictive value of noninducibility after catheter ablation for paroxysmal and persistent atrial fibrillation
by: Shinichi Tachibana, et al.
Published: (2020-06-01)

Atrial Fibrillation Catheter Ablation and Rhythm Control in Patients With Sickle Cell Disorders: A Propensity Score–Matched Analysis
by: Chad Gier, et al.
Published: (2024-01-01)

Comparison of two modes of long-term ECG monitoring to assess the efficacy of catheter ablation for paroxysmal atrial fibrillation
by: Jan Chovancik, et al.
Published: (2019-02-01)

Impact of Alcohol Consumption on the Outcome of Catheter Ablation in Patients With Paroxysmal Atrial Fibrillation
by: Masateru Takigawa, et al.
Published: (2016-12-01)

Catheter Ablation of Atrial Fibrillation
by: Chi Keong Ching, MD, et al.
Published: (2007-01-01)

Radiofrequency catheter ablation for drug-refractory paroxysmal atrial fibrillation in a patient with Ebstein’s anomaly
by: Yong-Giun Kim, MD, et al.
Published: (2017-01-01)

Antithrombotic Therapy in Patients with Paroxysmal Atrial Fibrillation after Catheter Treatment
by: O. R. Eshmatov, et al.
Published: (2023-05-01)

An Artificial Intelligence-Enabled ECG Algorithm for Predicting the Risk of Recurrence in Patients with Paroxysmal Atrial Fibrillation after Catheter Ablation
by: Junrong Jiang, et al.
Published: (2023-03-01)

Catheter Ablation of Atrial Fibrillation in Patients With Functional Mitral Regurgitation and Left Ventricular Systolic Dysfunction
by: Jin-Tao Wu, et al.
Published: (2020-12-01)

Decreased anxiety after catheter ablation for paroxysmal atrial fibrillation is associated with augmented parasympathetic reactivity to stress
by: Hideyuki Hasebe, MD, et al.
Published: (2020-08-01)

Percutaneous versus thoracoscopic ablation of symptomatic paroxysmal atrial fibrillation: a randomised controlled trial - the FAST II study
by: Jesper Eske Sindby, et al.
Published: (2018-10-01)

Paroxysmal Atrial Fibrillation Catheter Ablation Outcome Depends on Pulmonary Veins Anatomy
by: Gabriel Odozynski, et al.
Published: (2018-10-01)

The Long-Term Results of Three Catheter Ablation Methods in Patients With Paroxysmal Atrial Fibrillation: A 4-Year Follow-Up Study
by: Ling You, et al.
Published: (2021-10-01)

ATRIAL FIBRILLATION CATHETER ABLATION: YESTERDAY, TODAY, TOMORROW
by: D. S. Lebedev
Published: (2019-02-01)

Catheter Ablation for the Management of Atrial Fibrillation: An Update of the Literature
by: Shahana Hussain, et al.
Published: (2023-08-01)

ATRIAL FIBRILLATION CATHETER ABLATION: YESTERDAY, TODAY, TOMORROW
by: D. S. Lebedev
Published: (2019-02-01)

Nationwide survey of catheter ablation for atrial fibrillation: The Japanese Catheter Ablation Registry of Atrial Fibrillation (J-CARAF) – Report on antiarrhythmic drug therapy
by: Yuji Murakawa, MD, et al.
Published: (2014-10-01)